Astera Labs, Inc. $ALAB Shares Sold by Timothy G. Youngquist 2020 Irrevocable Trust

Key Points

• Timothy G. Youngquist 2020 Irrevocable Trust cut its Astera Labs stake by 59.5% in the second quarter, selling 7,923 shares and retaining 5,395 shares worth approximately $2.61 million.
• Other institutional investors increased exposure, while insiders sold 631,979 shares valued at roughly $215.5 million over the past three months. Institutional investors own 60.47% of Astera Labs, and insiders own 10.40%.
• Astera Labs reported stronger-than-expected quarterly results, with $0.80 EPS and $392.4 million in revenue, up 104.5% year over year. Shares opened at $303.44, while analysts maintain a “Moderate Buy” consensus with a $333 average price target.

Timothy G. Youngquist 2020 Irrevocable Trust decreased its position in shares of Astera Labs, Inc. (NASDAQ:ALAB - Free Report) by 59.5% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 5,395 shares of the company's stock after selling 7,923 shares during the period. Astera Labs comprises approximately 0.5% of Timothy G. Youngquist 2020 Irrevocable Trust's holdings, making the stock its 23rd biggest holding. Timothy G. Youngquist 2020 Irrevocable Trust's holdings in Astera Labs were worth $2,606,000 at the end of the most recent quarter.

A number of other institutional investors have also recently added to or reduced their stakes in the company. Vanguard Group Inc. grew its stake in shares of Astera Labs by 0.6% during the fourth quarter. Vanguard Group Inc. now owns 13,827,506 shares of the company's stock valued at $2,300,344,000 after acquiring an additional 84,365 shares in the last quarter. BlackRock Inc. acquired a new position in shares of Astera Labs in the second quarter worth about $6,609,581,000. Atreides Management LP boosted its holdings in Astera Labs by 108.9% in the first quarter. Atreides Management LP now owns 3,365,787 shares of the company's stock valued at $368,890,000 after purchasing an additional 1,754,593 shares during the last quarter. State Street Corp boosted its holdings in Astera Labs by 32.5% in the fourth quarter. State Street Corp now owns 3,099,809 shares of the company's stock valued at $515,684,000 after purchasing an additional 760,358 shares during the last quarter. Finally, Geode Capital Management LLC grew its stake in Astera Labs by 4.5% during the 4th quarter. Geode Capital Management LLC now owns 2,429,078 shares of the company's stock valued at $403,598,000 after purchasing an additional 104,935 shares in the last quarter. Institutional investors and hedge funds own 60.47% of the company's stock.

Insider Buying and Selling

In other news, Director Manuel Alba sold 136,974 shares of the business's stock in a transaction on Wednesday, July 1st. The shares were sold at an average price of $442.01, for a total transaction of $60,543,877.74. Following the completion of the transaction, the director owned 1,287,524 shares of the company's stock, valued at approximately $569,098,483.24. The trade was a 9.62% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Stefan A. Dyckerhoff sold 3,505 shares of the company's stock in a transaction dated Thursday, August 6th. The stock was sold at an average price of $311.83, for a total transaction of $1,092,964.15. Following the transaction, the director owned 53,961 shares of the company's stock, valued at $16,826,658.63. This represents a 6.10% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 631,979 shares of company stock valued at $215,479,247 over the last three months. Corporate insiders own 10.40% of the company's stock.

Astera Labs Stock Down 5.2%

Shares of ALAB stock opened at $303.44 on Wednesday. The business has a 50 day moving average of $356.72 and a two-hundred day moving average of $242.75. Astera Labs, Inc. has a 52 week low of $97.89 and a 52 week high of $499.48. The company has a market cap of $52.64 billion, a P/E ratio of 150.22 and a beta of 3.84.

Astera Labs (NASDAQ:ALAB - Get Free Report) last announced its quarterly earnings results on Tuesday, August 4th. The company reported $0.80 earnings per share for the quarter, topping analysts' consensus estimates of $0.69 by $0.11. Astera Labs had a return on equity of 19.24% and a net margin of 30.74%.The business had revenue of $392.40 million for the quarter, compared to analysts' expectations of $360.85 million. During the same period in the prior year, the firm earned $0.44 EPS. The business's quarterly revenue was up 104.5% on a year-over-year basis. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. Analysts expect that Astera Labs, Inc. will post 2.7 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several equities research analysts have issued reports on the company. Royal Bank Of Canada lifted their price objective on Astera Labs from $425.00 to $500.00 and gave the stock an "outperform" rating in a report on Wednesday, August 5th. Barclays increased their target price on Astera Labs from $200.00 to $325.00 and gave the company an "equal weight" rating in a research note on Monday, July 20th. Citigroup reissued a "buy" rating on shares of Astera Labs in a research report on Wednesday, July 29th. Roth Capital restated a "buy" rating and issued a $450.00 price target on shares of Astera Labs in a research note on Wednesday, August 5th. Finally, Bank of America upped their price target on shares of Astera Labs from $240.00 to $450.00 and gave the company a "neutral" rating in a report on Tuesday, June 23rd. One analyst has rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and eight have given a Hold rating to the company's stock. Based on data from MarketBeat, Astera Labs presently has an average rating of "Moderate Buy" and a consensus price target of $333.00.

Astera Labs Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company's product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.

Want to see what other hedge funds are holding ALAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astera Labs, Inc. (NASDAQ:ALAB - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source